MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pfeiffer, S.
Right arrow Articles by Mayer, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pfeiffer, S.
Right arrow Articles by Mayer, B.

Vol. 53, Issue 4, 795-800, April 1998

Molecular Actions of a Mn(III)Porphyrin Superoxide Dismutase Mimetic and Peroxynitrite Scavenger: Reaction with Nitric Oxide and Direct Inhibition of NO Synthase and Soluble Guanylyl Cyclase

Silvia Pfeiffer, Astrid Schrammel, Doris Koesling, Kurt Schmidt, and Bernd Mayer

Institut für Pharmakologie und Toxikologie, Karl-Franzens Universität Graz, Universitätsplatz 2, A-8010 Graz, Austria (S.P., A.S., K.S., B.M.) and Institut für Pharmakologie, Freie Universität Berlin, Thielallee 67-73, D-14195 Berlin 33, Germany (D.K.)

Mn(III)tetrakis(1-methyl-4-pyridyl)porphyrin (MnTMPyP), described as a superoxide dismutase mimetic and peroxynitrite scavenger, has been used previously to investigate the cytotoxic potential of superoxide and peroxynitrite in several pathological models. Here we report on the interference of MnTMPyP with NO/cGMP signaling using cultured endothelial cells as well as purified soluble guanylyl cyclase (sGC) either activated by the NO donor 2,2-diethyl-1-nitroso-oxyhydrazine sodium salt (DEA/NO) or reconstituted with nitric oxide synthase (NOS). MnTMPyP inhibited endothelial cGMP accumulation induced by A23187 (0.3 µM) with an IC50 of 75.0 ± 10.4 µM but had no significant effect on the potency of the Ca2+ ionophore. Purified NOS was inhibited by MnTMPyP (IC50 = 5.5 ± 0.8 µM) because of an interference of the Mn-porphyrin with the reductase domain of the enzyme. The most pronounced actions of MnTMPyP were direct inhibition of sGC and scavenging of NO. Purified sGC stimulated with either Ca2+/calmodulin-activated NOS (in the presence of GSH) or DEA/NO (in the absence of GSH) was inhibited with IC50 values of 0.8 ± 0.09 µM and 0.6 ± 0.2 µM, respectively. In the presence of GSH, MnTMPyP was reduced to the Mn(II) complex, resulting in efficient scavenging of NO under these conditions. Our data demonstrate that MnTMPyP (i) interferes with the reductase domain of NOS, (ii) scavenges NO in the presence of GSH, and (iii) is a potent direct inhibitor of sGC. These results cast doubt on the usefulness of MnTMPyP and related Mn-porphyrin complexes as probes to study the involvement of peroxynitrite/superoxide in biological systems.


Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Toxicol SciHome page
B. J. Day and C. Kariya
A Novel Class of Cytochrome P450 Reductase Redox Cyclers: Cationic Manganoporphyrins
Toxicol. Sci., May 1, 2005; 85(1): 713 - 719.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
S. Zhao, Y. Zhang, Y. Gu, D. F. Lewis, and Y. Wang
Heme Oxygenase-1 Mediates Up-Regulation of Adhesion Molecule Expression Induced by Peroxynitrite in Endothelial Cells
Reproductive Sciences, October 1, 2004; 11(7): 465 - 471.
[Abstract] [PDF]


Home page
J. Physiol.Home page
M. d. C. P. Franco, Z. B. Fortes, E. H. Akamine, E. M. Kawamoto, C. Scavone, L. R. G. de Britto, M. N. Muscara, S. A. Teixeira, R. C. A. Tostes, M. H. C. Carvalho, et al.
Tetrahydrobiopterin improves endothelial dysfunction and vascular oxidative stress in microvessels of intrauterine undernourished rats
J. Physiol., July 1, 2004; 558(1): 239 - 248.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
I. Tommasini, P. Sestili, and O. Cantoni
Delayed Formation of Hydrogen Peroxide Mediates the Lethal Response Evoked by Peroxynitrite in U937 Cells
Mol. Pharmacol., April 1, 2002; 61(4): 870 - 878.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
B. J. Buckley and A. R. Whorton
Adaptive responses to peroxynitrite: increased glutathione levels and cystine uptake in vascular cells
Am J Physiol Cell Physiol, October 1, 2000; 279(4): C1168 - C1176.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Teubl, K. Groschner, S. D. Kohlwein, B. Mayer, and K. Schmidt
Na+/Ca2+ Exchange Facilitates Ca2+-dependent Activation of Endothelial Nitric-oxide Synthase
J. Biol. Chem., October 8, 1999; 274(41): 29529 - 29535.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Kurjak, P. Koppitz, V. Schusdziarra, and H. D. Allescher
Evidence for a feedback inhibition of NO synthesis in enteric synaptosomes via a nitrosothiol intermediate
Am J Physiol Gastrointest Liver Physiol, October 1, 1999; 277(4): G875 - G884.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. P. Brandes, G. Koddenberg, W. Gwinner, D.-y. Kim, H.-J. Kruse, R. Busse, and A. Mugge
Role of Increased Production of Superoxide Anions by NAD(P)H Oxidase and Xanthine Oxidase in Prolonged Endotoxemia
Hypertension, May 1, 1999; 33(5): 1243 - 1249.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Pfeiffer, A. Lass, K. Schmidt, and B. Mayer
Protein Tyrosine Nitration in Cytokine-activated Murine Macrophages. INVOLVEMENT OF A PEROXIDASE/NITRITE PATHWAY RATHER THAN PEROXYNITRITE
J. Biol. Chem., August 31, 2001; 276(36): 34051 - 34058.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics